Circulating non-coding RNAs as potential diagnostic biomarkers in liver diseases

Area of Science:

• Hepatology and Molecular Diagnostics
• Biomarker Discovery for Liver Disease

Background:

• Liver diseases represent a significant global health burden, necessitating improved diagnostic strategies.
• Early detection of liver injury is crucial for effective treatment and preventing disease progression.
• Liver disease involves altered immune responses and changes in gene expression and cytokine profiles.

Purpose of the Study:

• To review the potential of microRNAs (miRNAs) as diagnostic biomarkers for liver diseases.
• To explore the role of circulating miRNAs in the early detection and management of liver conditions.

Main Methods:

• Review of current literature on non-coding RNAs, specifically miRNAs, in liver disease.
• Analysis of how altered miRNA expression correlates with different stages of liver pathology.
• Investigation of circulating miRNAs as potential non-invasive diagnostic markers.

Main Results:

• Specific patterns of increasing or decreasing non-coding RNAs, including miRNAs, are associated with liver disease phases.
• MicroRNAs are emerging as key players in the diagnosis of various liver conditions.
• Circulating miRNAs offer a promising avenue for developing novel, early diagnostic tools.

Conclusions:

• MicroRNAs hold significant potential as diagnostic biomarkers for liver diseases.
• miRNA-based diagnostics can facilitate early detection, enabling timely intervention and improved patient prognosis.
• Further research into circulating miRNAs is warranted for clinical application in hepatology.